KIDNEYS

 

Cream with endocannabinoids effective in the treatment of pruritus due to kidney disease (news – 2005)                                        http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=207

 

Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells (full – 2006)                                         http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1751877&tool=pmcentrez

 

Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor                                                             (full – 2008)  http://endo.endojournals.org/cgi/content/full/149/11/5619?maxtoshow=&hits=80&RESULTFORMAT=&f  ulltext=cannabinoid&searchid=1&FIRSTINDEX=240&resourcetype=HWCIT

 

The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney. (abst – 2008)                                           http://www.ncbi.nlm.nih.gov/pubmed/18571910

 

Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4                                                                               (full – 2009)  http://www.fasebj.org/cgi/content/full/23/5/1503?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=c  annabis&searchid=1&FIRSTINDEX=2400&resourcetype=HWCIT

 

The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.                                                    (full – 2009)     http://www.fasebj.org/content/23/1/183.long

 

Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy       (full – 2010)  http://diabetes.diabetesjournals.org/content/59/4/1046.full?sid=0bc8e3fa-5275-4b19-8acc-4aec5dfac384

 

Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.  (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869084/?tool=pubmed

 

Expression of cannabinoid receptors in human kidney.                     (abst – 2010)

http://www.ncbi.nlm.nih.gov/pubmed/20607655

 

Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death                                                                    (full – 2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682269/

 

 

 

 

 

 

 

 

Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist.                                              (full – 2011)  http://jpet.aspetjournals.org/content/337/1/236.long

 

Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                                  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/

 

Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy.     (full – 2011)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161308/

 

Distinctive effects of plant protein sources on renal disease progression and associated cardiac hypertrophy in experimental kidney disease.                                                    (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21294251

 

Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease?                                                                 (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21269798

 

Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance.  (abst – 2011)                                       http://www.ncbi.nlm.nih.gov/pubmed/21877303

 

β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.                                                         (abst – 2012)     http://www.ncbi.nlm.nih.gov/pubmed/22326488

 

Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats. (abst – 2012)                                       http://www.ncbi.nlm.nih.gov/pubmed/22877651

 

AKI Associated with Synthetic Cannabinoids: A Case Series.             (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/23243266

 

Outbreak of kidney failure in Wyoming linked to “Spice”                (news – 2012)

http://news.yahoo.com/outbreak-kidney-failure-wyoming-linked-spice-024307988.html

 

Wyoming kidney failure outbreak linked to designer ‘blueberry spice’ drug, aka ‘legal marijuana’  (news – 2012)  http://www.naturalnews.com/035181_spice_recreational_drugs_kidney_failure.html

 

Blueberry “spice” in Wyoming linked to cases of renal failure                  (news – 2012)

http://www.thepoisonreview.com/2012/03/03/blueberry-spice-in-wyoming-linked-to-cases-of-renal-failure/

 

New health concerns about ‘fake pot’ in US              (news – 2012)

http://medicalxpress.com/news/2012-03-health-fake-pot.html

 

Acute Kidney Injury Associated with Synthetic Cannabinoid Use — Multiple States, 2012          (report – 2013)                        http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6206a1.htm

 

Cannabinoid Receptors as Therapeutic Targets for Dialysis-Induced Peritoneal Fibrosis. (abst – 2013)                                        http://www.ncbi.nlm.nih.gov/pubmed/23296044

 

 

 

 

 

 

 

 

 

Synthetic Marijuana Dangerous for Kidneys                      (news – 2013)

http://www.sciencedaily.com/releases/2013/02/130208124553.htm

 

Synthetic Marijuana Harms Kidneys of 16 Users, CDC Reports                      (news – 2013)

http://news.yahoo.com/synthetic-marijuana-harms-kidneys-16-users-cdc-reports-170208780.html

Share a link for